Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.

S 3837 requires NJ FamilyCare to pay inpatient hospitals the same rate for long-acting injectable antipsychotic drugs (used to treat conditions like schizophrenia and bipolar disorder) as it pays for the same drugs in outpatient settings. Currently, hospitals receive a fixed payment for inpatient care that doesn't account for the high cost of these specific medications. The bill mandates that reimbursement for these drugs in hospitals must be separate from standard inpatient payments and equal to the outpatient rate. This change aims to better reflect the actual drug costs, potentially increasing access to these treatments in hospitals for patients with serious mental illness.